European Society for Medical Oncology
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
European Society for Medical Oncology
May 18, 2024, 03:08 |
Blog
AI in Breast Cancer management is revolutionising the field - ESMO
ESMO shared a post on LinkedIn: "The rapid integration of Artificial Intelligence in Breast Cancer…
May 18, 2024, 01:30 |
Blog
Eva Schumacher-Wulf: Best poster prize at ESMOBreast24!
Eva Schumacher-Wulf, Editor-in-Chief of Mamma Mia! Magazine, shared on X: "More than proud about the…
May 13, 2024, 12:54 |
Blog
Become part of the conversation about the science presented at ESMO Breast24
European Society for Medical Oncology shared on their X page: "Do not miss the latest…
May 12, 2024, 14:34 |
Societies
Tom Powles talks to Amanda Psyrri about immune cell-related biomarkers in HNSCC - ESMO
ESMO - European Society for Medical Oncology shared on LinkedIn: “Latest podcast Annals of Oncology…
May 12, 2024, 12:13 |
Insight
Herbert Loong: 6 versus 3 years of adjuvant imatinib in high risk GISTs by Jean-Yves Blay et al.
Herbert Loong shared on LinkedIn: “Congrats Jean-Yves Blay and colleagues of French Sarcoma Group for completing…
May 7, 2024, 05:04 |
Blog
Aruni Ghose: United Kingdom’s First Real World Evidence of Sacituzumab Govitecan in mTNBC
Aruni Ghose, Editorial Board Member at BMC, shared a post on LinkedIn: "My favourite Registrar Mentor…
May 5, 2024, 04:18 |
Blog
Erman Akkus summaries Merkel-cell carcinoma guideline of ESMO and EURACAN
Erman Akkus, Medicine Oncology and Internal Medicine Specialist at Ankara University, shared on X/Twitter: "Merkel-cell…
May 5, 2024, 00:40 |
Blog
Martin Harutyunyan: ESMO Preceptorship course on Supportive and Palliative Care
Martin Harutyunyan, Medical Oncologist at the Yeolyan Hematology and Oncology Center, shared a post on LinkedIn:…
Apr 26, 2024, 12:00 |
Blog
Vivek Subbiah: Window of opportunity (WOO) studies across cancer subtypes by Barbara Pistilli
Vivek Subbiah shared a post on X/Twitter: "Window of opportunity (WOO) studies across cancer subtypes?…
Mar 26, 2024, 19:04 |
Societies
Federica Giugliano: I am happy to be awarded by ESMO with a merit travel grant to attend ESMO Breast Cancer 2024 in Berlin
Federica Giugliano, Research Fellow at Gustave Roussy Institute, shared on LinkedIn: “I am happy to…
1
2
All:
16
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube